Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Finished Goods (2017 - 2025)

Dexcom (DXCM) has disclosed Finished Goods for 12 consecutive years, with $266.5 million as the latest value for Q4 2025.

  • Quarterly Finished Goods rose 42.21% to $266.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $266.5 million through Dec 2025, up 42.21% year-over-year, with the annual reading at $266.5 million for FY2025, 42.21% up from the prior year.
  • Finished Goods for Q4 2025 was $266.5 million at Dexcom, up from $259.5 million in the prior quarter.
  • The five-year high for Finished Goods was $266.5 million in Q4 2025, with the low at $107.9 million in Q1 2025.
  • Average Finished Goods over 5 years is $187.5 million, with a median of $190.5 million recorded in 2023.
  • The sharpest move saw Finished Goods soared 209.87% in 2021, then crashed 54.68% in 2025.
  • Over 5 years, Finished Goods stood at $195.9 million in 2021, then plummeted by 33.38% to $130.5 million in 2022, then surged by 61.0% to $210.1 million in 2023, then fell by 10.8% to $187.4 million in 2024, then surged by 42.21% to $266.5 million in 2025.
  • According to Business Quant data, Finished Goods over the past three periods came in at $266.5 million, $259.5 million, and $130.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.